Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BioXcel Therapeutics Inc BTAI

BioXcel Therapeutics, Inc. is a biopharmaceutical company utilizing artificial intelligence to develop medicines in neuroscience. Its subsidiary, OnkosXcel Therapeutics, develops medicines in immuno-oncology. The Company’s most advanced neuroscience candidate, BXCL501, is an investigational, proprietary, orally dissolving film formulation of Dex in development for the treatment of agitation... see more

Bullboard (NDAQ:BTAI)

View:
Post by whytestockson Sep 19, 2024 7:32pm

BioXcel Therapeutics Announces Clinical Prioritization and U

Breaking News: $BTAI BioXcel Therapeutics Announces Clinical Prioritization and Update on BXCL501 Late-Stage Programs for AgitationRecently initiated SERENITY At-Home pivotal Phase 3 trial for ...more  
Post by MikeTesteron Aug 02, 2024 2:07pm

BioXcel Therapeutics, Inc. (NASDAQ:BTAI): Advancing Neurosci

https://beyondspx.com/2024/07/31/bioxcel-therapeutics-inc-nasdaqbtai-advancing-neuroscience-and-immuno-oncology-pipelines-driving-igalmi-commercialization/
Post by whytestockson Feb 13, 2024 1:15pm

Why BioXcel Therapeutics Shares Are Rising Tuesday | Benzing

BREAKING NEWS: $BTAI Why BioXcel Therapeutics Shares Are Rising Tuesday | BenzingaBioXcel Therapeutics, Inc.@(NASDAQ:BTAI) shares are@jumping on Tuesday.The company announced that it has terminated ...more  
Post by whytestockson Feb 13, 2024 11:45am

BioXcel Therapeutics Announces Termination of Proposed Publi

BREAKING NEWS: $BTAI BioXcel Therapeutics Announces Termination of Proposed Public OfferingNEW HAVEN, Conn., Feb. 13, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a ...more  
Post by whytestockson Feb 09, 2024 9:15pm

BIOXCEL ALERT: Bragar Eagel & Squire, P.C. is Investigating

BREAKING NEWS: $BTAI BIOXCEL ALERT: Bragar Eagel & Squire, P.C. is Investigating BioXcel Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm ...more  
Post by whytestockson Feb 06, 2024 4:15pm

BioXcel Therapeutics Announces Completion of Patient Enrollm

Breaking News: $BTAI BioXcel Therapeutics Announces Completion of Patient Enrollment in Safety Portion of Investigator-Sponsored Phase 2 Relapsed Pancreatic Cancer Trial of BXCL701 in Combination with ...more  
Post by JGrabaron Nov 30, 2023 1:36pm

$BTAI Shareholder Investigation

https://grabarlaw.com/the-latest/bioxcel-shareholder-investigation/ A recently filed securities fraud class action complaint alleges that BioXcel Therapeutics Inc. (NASDAQ: BTAI), via certain ...more  
Post by whytestockson Jul 18, 2023 4:00pm

BTAI Investors Have Opportunity to Lead BioXcel Therapeutics

BREAKING NEWS: $BTAI BTAI Investors Have Opportunity to Lead BioXcel Therapeutics, Inc. Securities Fraud LawsuitBTAI Investors Have Opportunity to Lead BioXcel Therapeutics, Inc. Securities Fraud ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities